Evidence map›Paper›PMID 31866440›Full record

ArticleTicks and tick-borne diseases2020

A soft tick Ornithodoros moubata salivary protein OmCI is a potent inhibitor to prevent avian complement activation.

Amber M Frye, Thomas M Hart, Danielle M Tufts, Sanjay Ram, Maria A Diuk-Wasser, Peter Kraiczy, Anna M Blom, Yi-Pin Lin

Open access · greenAbstract read
In one paragraph

Article in Ticks and tick-borne diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Structural evolution of an immune evasion determinant shapes pathogen host tropism.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Immunomodulatory Proteins in Tick Saliva From a Structural Perspective.Frontiers in cellular and infection microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Amber M FryeDepartment of Biomedical Sciences, State University of New York at Albany, Albany, NY, USA; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA.
Thomas M HartDivision of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA; Department of Biological Sciences, State University of New York at Albany, Albany, NY, USA.
Danielle M TuftsDepartment of Ecology, Evolution, and Environmental Biology, Columbia University, New York, NY, USA.
Sanjay RamDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Maria A Diuk-WasserDepartment of Ecology, Evolution, and Environmental Biology, Columbia University, New York, NY, USA.
Peter KraiczyInstitute of Medical Microbiology and Infection Control, University Hospital of Frankfurt, Frankfurt, Germany.
Anna M BlomDivision of Medical Protein Chemistry, Department of Translational Medicine, Lund University, Malmo, Sweden.
Yi-Pin LinDepartment of Biomedical Sciences, State University of New York at Albany, Albany, NY, USA; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA. Electronic address: Yi-Pin.Lin@health.ny.gov.
Columbia University · USUniversity at Albany, State University of New York · USLund University · SEUniversity Hospital Frankfurt · DEUniversity of Massachusetts Chan Medical School · USWadsworth Center · US

Funding

Multiple B. burgdorferi Factors Collaborate to Evade Complement-Mediated DefensesR01AI121401 · NIAID · TUFTS UNIVERSITY BOSTON · PI COBURN, JENIFER L, LEONG, JOHN M · 2016 to 2020
$3.1M
NCEZID CDC HHS U01 CK000509NIAID NIH HHS R01 AI121401
6 · The paper itself

Abstract

Complement is a key first line innate host defense system in the blood of vertebrates. Upon activation, this powerful defense mechanism can elicit inflammatory responses, lyse non-self-cells, or mark them for opsonophagocytic removal. Blood-feeding arthropods thus require the ability to block host complement activation in the bloodmeal to prevent undesired cell or tissue damage during feeding. The soft tick Ornithodoros moubata produces a complement inhibitory protein, OmCI. This protein binds to a mammalian complement protein C5 and blocks further activation of complement cascades, which results in the prevention of complement-mediated bacterial killing through membrane attack complex. Interestingly, the amino acids involved in OmCI binding are highly conserved among mammalian and avian C5, but the ability of this protein to inhibit the complement from birds remains unclear. Here we demonstrated that OmCI is capable of preventing quail complement-mediated erythrocyte lysis, inhibiting the capability of this animal's complement to eliminate a serum-sensitive Lyme disease bacterial strain. We also found that the ability of OmCI to inhibit quail complement-mediated killing of Lyme disease bacteria can be extended to different domestic and wild birds. Our results illustrate the utility of OmCI to block bird complement. These results provide the foundation for further use of this protein as a tool to study the molecular basis of avian complement and pathogen evasion to such a defense mechanism.

Indexed as

Protein BindingAmino Acid SequenceAnimalsArthropod ProteinsComplement ActivationComplement C5CoturnixOrnithodorosPeromyscusSalivary Proteins and PeptidesSequence AlignmentArthropod ProteinsComplement C5Salivary Proteins and PeptidesAvian complementBacterial killingLyme borreliaeOmCI

Identifiers

PMID31866440
PMCPMC6997930
OpenAlexW2993755886

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.